Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.
Acadia Pharmaceuticals Inc. (ACAD) has a market cap of $3.75B with year-over-year revenue growth of +31.8%. Net margin stands at 23.6%. The stock trades at a P/E ratio of 16.6.
Compared to other companies in the PHARMACEUTICAL PREPARATIONS sector, ACAD posted revenue growth of +31.8% and trades at a P/E of 16.6.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.